CORT Financial Facts

Net loss and comprehensive loss: -6.01M
Basic and diluted net loss per share: -0.06
See Full Income Statement

Total liabilities and stockholders' equity: 37.16M
Prepaid expenses and other current assets: 1.77M
See Full Balance Sheet

Corcept Therapeutics (CORT) Earnings

  |   Expand Research on CORT
Next EPS Date 5/7/15 *Est. EPS Growth Rate +81.8% *Last Qtr.
Average EPS % Beat Rate +16.9% Revenue Growth Rate +119.8% *Last Qtr.
Average % Move 1-Wk after EPS -8.5% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/4/15 Q414 -$0.02-$0.06 +$0.04$9.01M$9.1M N/A Details
11/4/14 Q214 N/A-$0.07 N/A N/A$7.62M N/A N/A N/A
5/7/14 Q114 -$0.11-$0.09 -$0.02$4.41M$5.01M N/A Details
3/5/14 Q413 -$0.11-$0.10 -$0.01$4.1M$4.01M N/A Details
11/7/13 Q313 -$0.08-$0.12 +$0.04$2.6M$2.7M N/A Details
8/8/13 Q213 -$0.10-$0.11 +$0.01$1.9M$2.72M N/A Details
5/2/13 Q113 -$0.10-$0.09 -$0.01$1.72M$2.48M N/A Details
3/7/13 Q412 -$0.09-$0.09 $0.00$1.38M$1.5M N/A Details